Therapie
Therapie
· ISSN (print) 0040-5957
· 2 papers in corpus
2023
IntroductionTwo severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines, tozinameran/BNT162b2 (Comirnaty®, Pfizer-BioNTech) and elasomeran/mRNA-1273 (Spikevax®, Moderna), were approved by the Food and Drug…
article
1973